{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:09:53Z","timestamp":1771956593374,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jcrc.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T07:45:56Z","timestamp":1344498356000},"page":"219.e1-219.e12","source":"Crossref","is-referenced-by-count":31,"title":["Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan"],"prefix":"10.1016","volume":"28","author":[{"given":"Bruce","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Cirulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2012.06.001_bb0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin","volume":"102","author":"Anderson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0248-8663(02)00811-1","article-title":"Incidence, causes and prognostic factors of hyponatremia in intensive care","volume":"24","author":"Bennani","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000078883","article-title":"Dysnatremias in the critical care setting","volume":"144","author":"Moritz","year":"2004","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfi082","article-title":"Development of severe hyponatremia in hospitalized patients: treatment-related risk factors and inadequate management","volume":"21","author":"Hoorn","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MCC.0b013e32830e45e3","article-title":"Diagnosis and management of hyponatremia in acute illness","volume":"14","author":"Schrier","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0030","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1186\/cc7162","article-title":"The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units","volume":"12","author":"Stelfox","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-009-1692-0","article-title":"Incidence and prognosis of dysnatremias present on ICU admission","volume":"36","author":"Funk","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCG.0b013e3181aabbcd","article-title":"Serum sodium predicts prognosis in critically ill cirrhotic patients","volume":"44","author":"Jenq","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12630-010-9309-1","article-title":"Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery","volume":"57","author":"Stelfox","year":"2010","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ecl.2006.09.011","article-title":"Disorders of body water homeostasis in critical illness","volume":"35","author":"Adler","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl. 1","key":"10.1016\/j.jcrc.2012.06.001_bb0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0060","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2146\/ajhp040300","article-title":"Treatment of electrolyte disorders in adult patients in the intensive care unit","volume":"62","author":"Kraft","year":"2005","journal-title":"Am J HealthSyst Pharm"},{"issue":"Suppl.","key":"10.1016\/j.jcrc.2012.06.001_bb0065","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1097\/CCM.0b013e3181dda0be","article-title":"Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit","volume":"38","author":"Buckley","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0070","first-page":"163","article-title":"Incidence and etiology of hyponatremia in an intensive care unit","volume":"34","author":"DeVita","year":"1990","journal-title":"Clin Nephrol"},{"issue":"3-4","key":"10.1016\/j.jcrc.2012.06.001_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.wneu.2011.03.042","article-title":"Hyponatremia in patients with traumatic brain injury: etiology, incidence, and severity correlation","volume":"76","author":"Lohani","year":"2011","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","article-title":"Mortality and hospitalization with mild, moderate, and severe hyponatremia","volume":"122","author":"Waikar","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0085","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.2006030240","article-title":"Body water homeostasis: clinical disorders of urinary dilution and concentration","volume":"17","author":"Schrier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0090","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s00134-001-1132-2","article-title":"The impact of delirium in the intensive care unit on hospital length of stay","volume":"27","author":"Ely","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit","volume":"291","author":"Ely","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0105","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1034\/j.1600-0579.2003.00201.x","article-title":"Delirium in the intensive care unit: occurrence and clinical course in older patients","volume":"51","author":"McNicoll","year":"2003","journal-title":"J Am GeriatrSoc"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0115","doi-asserted-by":"crossref","first-page":"R375","DOI":"10.1186\/cc3729","article-title":"Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients","volume":"9","author":"Thomason","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/cc1044","article-title":"Predisposing factors for delirium in the surgical intensive care unit","volume":"5","author":"Aldemir","year":"2001","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.semnephrol.2009.03.002","article-title":"The treatment of hyponatremia","volume":"29","author":"Sterns","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0130","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1530\/EJE-09-1057","article-title":"The syndrome of inappropriate antidiuretic hormone: current and future management options","volume":"162","author":"Sherlock","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9343(01)00678-7","article-title":"Longterm treatment of patients with inappropriate secretion of ADH by vasopressin receptor antagonist conivaptan, urea or furosemide","volume":"110","author":"Decaux","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.283.6299.1081","article-title":"Urea for long-term treatment of the syndrome of inappropriate secretion of ADH","volume":"283","author":"Decaux","year":"1981","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0145","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000187255","article-title":"5-year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea","volume":"63","author":"Decaux","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0155","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1001\/jama.1980.03300500039026","article-title":"Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients","volume":"243","author":"Miller","year":"1980","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.jcrc.2012.06.001_bb0160","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.3949\/ccjm.73.Suppl_3.S24","article-title":"AVP receptor antagonists as aquaretics: review and assessment of clinical data","volume":"73","author":"Verbalis","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0165","unstructured":"Vaprisol\u00ae (conivaptan hydrochloride) [prescribing information]. Deerfield, IL: Astellas Pharma US, Inc; February 2011."},{"key":"10.1016\/j.jcrc.2012.06.001_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0175","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1AV2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"91","author":"Ghali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e31817b8148","article-title":"Conivaptan Study Group. Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"337","author":"Annane","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0185","unstructured":"Samsca\u2122 (tolvaptan) [prescribing information]. Rockville, MD: Otsuka America Pharmaceutical, Inc; May 2009."},{"key":"10.1016\/j.jcrc.2012.06.001_bb0190","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.amjcard.2005.10.050","article-title":"Tolvaptan Investigators. Vasopressin V2 receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia","volume":"97","author":"Gheorghiade","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0195","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0200","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0205","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"SALT Investigators. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3111\/13696998.2011.643329","article-title":"Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial","volume":"15","author":"Chiong","year":"2012","journal-title":"J Med Econ"},{"issue":"4","key":"10.1016\/j.jcrc.2012.06.001_bb0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2146\/ajhp100217","article-title":"Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure","volume":"68","author":"Cyr","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0225","doi-asserted-by":"crossref","unstructured":"Dasta JF, Chiong JR, Christian R, Lin J. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials. Hospital Practice 2012. DOI: 10.3810\/hp.2012.02.942.","DOI":"10.3810\/hp.2012.02.942"},{"key":"10.1016\/j.jcrc.2012.06.001_bb0230","unstructured":"Red Book\u00ae: Pharmacy's Fundamental Reference. August Update, 2009 Edition. Montvale, NJ; 2009."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944112001761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944112001761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T11:23:20Z","timestamp":1542799400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944112001761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0883944112001761"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2012.06.001","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}